Uncategorized

Lantheus Enters Strategic Collaboration with Cerevast for Potential New Eye Care Application Using Microbubbles

by Business Wire • 2019/04/02 • 0 Comments

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Enters Strategic Collaboration with Cerevast for Potential New Eye Care Application Using Microbubbles

Full Story →

← Aerie Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference

Ocular Therapeutix™ Announces Notification of FDA Acceptance of Supplemental New Drug Submission for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery →

Post navigation